Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study
2022Clinical and Applied Thrombosis/HemostasisJournalOpen access
10.1177/10760296221126176Full text0 citations